The REPLACE Registry

Overview

About this study

This is a prospective, observational, non-interventional patient registry designed to document long term safety and clinical outcomes for 10 years in patients treated with Cholbam/Kolbam, including those who have been using Cholbam/Kolbam and those who start Cholbam/Kolbam treatment at enrollment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Male and female patients, of any age.
The patient has a diagnosis for which Cholbam/Kolbam is indicated.
The patient is treated with Cholbam/Kolbam at enrollment.

Exclusion Criteria:

Patients who will not be able to comply with the requirements of the protocol will be excluded.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Katryn Furuya, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Katryn Furuya, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials